LA 20% Oxytetracycline Jekiseni
Composition
1 ml zveLA Oxytetracycline jekiseni 20%rineOxytetracyclinedihydrate yakaenzana ne200 mg base.
Indication
Kushandiswa kwe tetracycline kunoratidzwa muzvirwere zve systemic uye zvemunharaunda zvakadai seBronchopneumon ia, bacterial enteritis, urinary tract infections, cholang itis, Metritis, mastitis, pyodermia, Anthrax, Diphtheria uye CRD.
Zvakananga zviratidzo zvehwai, Mbudzi & Mombe zvirwere zvekufema, mastitis, metritis, chlamydiosis, uye zvirwere zve cornea, conjunctiva uye utachiona hweronda;
Chiratidzo chehuku chirwere chisingaperi chekufema (CRD) Colibacillosis uye fowl cholera.
Dosage
Chiyero chikuru ndechekuti: 10-20mg/kg uremu hwemuviri, zuva nezuva.
Vakuru: 0.5ml/10kg, mhuka duku 1ml/ 10kg uremu hwemuviri
Mombe, ngamera, hwai, mbudzi: jekiseni rimwe chete pachiyero che 20 mg oxytetracycline pakg yehuremu hwemuviri kana 1 ml pa10 kg uremu hwemuviri.
Administration nzira
Intramuscular injection
Dosage interval
Dzokorora jekiseni rechipiri mushure memazuva 2-4
Toxicology
Mhedzisiro yakaoma nekuda kwekushandiswa kwe tetracycline haiwanzo kucherechedzwa
Migumisiro yakaipa
Zvakaipa zvinokonzerwa nekushandiswa kwe tetracycline ndezvekuti: kukanganiswa kwemaitiro, photosensitivity, kushanduka kwemazino pazera rezera rezera uye hepatoxicity, oxytetracycline inogonawo kukonzera kutsamwa kwetishu panzvimbo yejekiseni.
Contra indication
Chiratidzo chekushandiswa kwe tetracycline ndiko kukanganisa kwakanyanya kwechiropa kana itsvo uye dzimwe nguva hypersensitivity kune tetracycline.
Therapeutic incom patibilities
Tetracycline haifaniri kusanganiswa nemishonga inorwisa mabhakitiriya yakadai sepenicill1nes, cephalosporins.Kutorwa kwe tetracycline kunodzivirirwa kana kuchipihwa panguva imwe chete negadziriro dzine divalent cations.Kusanganiswa kwe tetracycline ine macrolides akadai setylosin uye polymyxins senge colistin, inoshanda synergistically.
Yakakurudzirwa kubvisa nguva
Nyama: 21 mazuva
Mukaka, Mazai: 07 mazuva
Mashoko
Chengetedza pasi pe25 ℃, chengetedza kubva kuchiedza.
Chengetedza pasingasvikirwi nevana.
Usashandise kana mhinduro ikava turbid kana dema.
Nguva dzose bvunza chiremba wemhuka usati washandisa mushonga.
Hebei Veyong Pharmaceutical Co., Ltd, yakavambwa muna 2002, iri muShijiazhuang City, Hebei Province, China, padyo neguta guru Beijing.Iye ihombe GMP-yakasimbiswa veterinary drug bhizinesi, ine R&D, kugadzira uye kutengesa kweVeterinary APIs, gadziriro, premixed feed uye feed additives.SeProvincial Technical Center, Veyong yakamisa hurongwa hweR&D hwemishonga mitsva yezvipfuyo, uye ndiyo inozivikanwa pasi rose tekinoroji innovation yakavakirwa bhizinesi rezvipfuyo, kune makumi matanhatu neshanu nyanzvi.Veyong ine mabhesi maviri ekugadzira: Shijiazhuang neOrdos, iyo iyo Shijiazhuang base inovhara nzvimbo ye78,706 m2, ine 13 API zvigadzirwa zvinosanganisira Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, uye 11, gadziriro yekugadzira oral poda, mitsara yekugadzira oral. , premix, bolus, mishonga yezvipembenene nemishonga inouraya utachiona, ects.Veyong inopa APIs, anopfuura zana ega- label gadziriro, uye OEM & ODM sevhisi.
Veyong inokoshesa zvikuru manejimendi eEHS(Environment, Health & Safety) system, uye yakawana ISO14001 uye OHSAS18001 zvitupa.Veyong yakanyorwa mumabhizinesi ari kusimukira maindasitiri muHebei Province uye inogona kuve nechokwadi chekuenderera mberi kwezvigadzirwa.
Veyong yakamisa hurongwa hwekutonga kwemhando yakakwana, yakawana chitupa cheISO9001, chitupa cheChina GMP, chitupa cheAustralia APVMA GMP, chitupa cheEthiopia GMP, chitupa cheIvermectin CEP, uye yakapasa ongororo yeUS FDA.Veyong ine timu yehunyanzvi yekunyoresa, kutengesa uye tekinoroji sevhisi, kambani yedu yakawana kuvimba nerutsigiro kubva kune akawanda vatengi nemhando yepamusoro yechigadzirwa, yepamusoro-yemhando yepamusoro-yekutanga kutengesa uye mushure mekutengesa sevhisi, yakakomba uye yesainzi manejimendi.Veyong yaita kushandira pamwe kwenguva refu nemabhizinesi mazhinji anozivikanwa pasi rose emishonga yemhuka ane zvigadzirwa zvinotengeswa kuEurope, South America, Middle East, Africa, Asia, etc. kupfuura nyika makumi matanhatu nematunhu.